论文部分内容阅读
目的分析血清CA125、CA199与CEA联合检测在卵巢癌诊断中的应用价值。方法将患者分为观察组与对照一组和对照二组,分别进行血清CA125、CA199与CEA几项指标的检测,比较分析3组血清CA125、CA199与CEA的平均水平,并对3组单独检测和联合检测血清CA125、CA199与CEA的阳性率情况进行对比分析。结果观察组患者血清CA125、CA199与CEA几项相关指标水平明显高于对照一组和对照二组;另外,观察组联合检测较之单独检测,阳性率明显高,且明显高于对照一组和对照二组差异有统计学意义(P<0.05)。结论血清CA125、CA199与CEA联合检测用于卵巢癌的诊断具有较高的敏感性,可提供一定参照价值,值得临床推广。
Objective To analyze the value of combined detection of serum CA125, CA199 and CEA in the diagnosis of ovarian cancer. Methods The patients were divided into two groups: observation group, control group and control group. The serum CA125, CA199 and CEA levels were measured respectively. The average levels of serum CA125, CA199 and CEA in three groups were compared and analyzed. And the combined detection of serum CA125, CA199 and CEA positive rate of comparative analysis. Results The serum levels of CA125, CA199 and CEA in the observation group were significantly higher than those in the control group and the control group. In addition, the positive rate of combined detection in the observation group was significantly higher than that in the control group and significantly higher than that in the control group The difference between the two groups was statistically significant (P <0.05). Conclusion The combined detection of serum CA125, CA199 and CEA for the diagnosis of ovarian cancer has a high sensitivity, which can provide some reference value, worthy of clinical promotion.